{"denoms":[{"counts":[{"groupId":"BG000","value":"225"},{"groupId":"BG001","value":"215"},{"groupId":"BG002","value":"440"}],"units":"Participants"}],"groups":[{"description":"Intravenous palonosetron (Aloxi 0.25 mg solution for injection) as an infusion with oral dexamethasone, both given on Day 1, prior to the scheduled start of cisplatin; then dexamethasone from Days 2 through 4.\n\nPalonosetron\n\nDexamethasone","id":"BG000","title":"I.V. Palonosetron Infusion Plus Dexamethasone"},{"description":"Intravenous palonosetron (Aloxi 0.25 mg solution for injection) as a bolus with oral dexamethasone, both given on Day 1, prior to the scheduled start of cisplatin; then dexamethasone from Days 2 through 4.\n\nPalonosetron\n\nDexamethasone","id":"BG001","title":"I.V. Palonosetron Bolus Plus Dexamethasone"},{"description":"Total of all reporting groups","id":"BG002","title":"Total"}],"measures":[{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","spread":"8.7","value":"59.9"},{"groupId":"BG001","spread":"8.5","value":"58.9"},{"groupId":"BG002","spread":"8.6","value":"59.4"}]}]}],"dispersionType":"STANDARD_DEVIATION","paramType":"MEAN","title":"Age, Continuous","unitOfMeasure":"years"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"74"},{"groupId":"BG001","value":"71"},{"groupId":"BG002","value":"145"}],"title":"Female"},{"measurements":[{"groupId":"BG000","value":"151"},{"groupId":"BG001","value":"144"},{"groupId":"BG002","value":"295"}],"title":"Male"}]}],"paramType":"COUNT_OF_PARTICIPANTS","title":"Sex: Female, Male","unitOfMeasure":"Participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"0"},{"groupId":"BG001","value":"0"},{"groupId":"BG002","value":"0"}],"title":"American Indian or Alaska Native"},{"measurements":[{"groupId":"BG000","value":"0"},{"groupId":"BG001","value":"0"},{"groupId":"BG002","value":"0"}],"title":"Asian"},{"measurements":[{"groupId":"BG000","value":"0"},{"groupId":"BG001","value":"0"},{"groupId":"BG002","value":"0"}],"title":"Native Hawaiian or Other Pacific Islander"},{"measurements":[{"groupId":"BG000","value":"0"},{"groupId":"BG001","value":"0"},{"groupId":"BG002","value":"0"}],"title":"Black or African American"},{"measurements":[{"groupId":"BG000","value":"225"},{"groupId":"BG001","value":"215"},{"groupId":"BG002","value":"440"}],"title":"White"},{"measurements":[{"groupId":"BG000","value":"0"},{"groupId":"BG001","value":"0"},{"groupId":"BG002","value":"0"}],"title":"More than one race"},{"measurements":[{"groupId":"BG000","value":"0"},{"groupId":"BG001","value":"0"},{"groupId":"BG002","value":"0"}],"title":"Unknown or Not Reported"}]}],"paramType":"COUNT_OF_PARTICIPANTS","title":"Race (NIH/OMB)","unitOfMeasure":"Participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"97"},{"groupId":"BG001","value":"109"},{"groupId":"BG002","value":"206"}],"title":"Grade 0"},{"measurements":[{"groupId":"BG000","value":"120"},{"groupId":"BG001","value":"100"},{"groupId":"BG002","value":"220"}],"title":"Grade 1"},{"measurements":[{"groupId":"BG000","value":"8"},{"groupId":"BG001","value":"6"},{"groupId":"BG002","value":"14"}],"title":"Grade 2"}]}],"description":"The ECOG Scale is a standard criteria for measuring how the cancer disease impacts a patient's daily living abilities (known to physicians and researchers as a patient's performance status). It describes a patient's level of functioning in terms of their ability to care for themself, daily activity, and physical ability (walking, working, etc.). There 6 grades, where the performance gets worsening from 0 (patient is fully active, able to carry on all pre-disease performance without restriction) to 5 (patient is dead).","paramType":"COUNT_OF_PARTICIPANTS","title":"ECOG Performance Status","unitOfMeasure":"Participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"160"},{"groupId":"BG001","value":"145"},{"groupId":"BG002","value":"305"}],"title":"None"},{"measurements":[{"groupId":"BG000","value":"58"},{"groupId":"BG001","value":"67"},{"groupId":"BG002","value":"125"}],"title":"Occasional"},{"measurements":[{"groupId":"BG000","value":"7"},{"groupId":"BG001","value":"3"},{"groupId":"BG002","value":"10"}],"title":"Regular"}]}],"paramType":"COUNT_OF_PARTICIPANTS","title":"Alcohol consumption","unitOfMeasure":"Participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"81"},{"groupId":"BG001","value":"77"},{"groupId":"BG002","value":"158"}],"title":"non-smoker"},{"measurements":[{"groupId":"BG000","value":"81"},{"groupId":"BG001","value":"70"},{"groupId":"BG002","value":"151"}],"title":"Ex-smoker"},{"measurements":[{"groupId":"BG000","value":"60"},{"groupId":"BG001","value":"66"},{"groupId":"BG002","value":"126"}],"title":"Regular"},{"measurements":[{"groupId":"BG000","value":"3"},{"groupId":"BG001","value":"2"},{"groupId":"BG002","value":"5"}],"title":"Occasional"}]}],"paramType":"COUNT_OF_PARTICIPANTS","title":"Tobacco consumption","unitOfMeasure":"Participants"}]}